Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost‐effective therapy with a 2‐year follow‐up

Click here for the corresponding questions to this CME article.

Saved in:

Bibliographic Details
Published in:	Clinical and experimental dermatology Vol. 44; no. 5; pp. 577 - 579
Main Authors:	Sardana, K., Bajaj, S., Bose, S. K.
Format:	Journal Article
Language:	English
Published:	England Oxford University Press 01-07-2019
Subjects:	Acne Vulgaris - drug therapy Acne Vulgaris - economics Acne Vulgaris - pathology Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - economics Anti-Inflammatory Agents - therapeutic use Antibiotics Arthritis, Infectious - drug therapy Arthritis, Infectious - economics Arthritis, Infectious - pathology Cost-Benefit Analysis Dapsone Dapsone - administration & dosage Dapsone - therapeutic use Dermatologic Agents - administration & dosage Dermatologic Agents - economics Dermatologic Agents - therapeutic use Drug Therapy, Combination - economics Humans Methotrexate Methotrexate - administration & dosage Methotrexate - therapeutic use Minocycline Minocycline - administration & dosage Minocycline - therapeutic use Pregnenediones - administration & dosage Pregnenediones - therapeutic use Pyoderma Gangrenosum - drug therapy Pyoderma Gangrenosum - economics Pyoderma Gangrenosum - pathology Skin - pathology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Click here for the corresponding questions to this CME article.
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	0307-6938 1365-2230
DOI:	10.1111/ced.13792